Dept of Medical Oncology - external affiliates

Research output

Research output per year 2003 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

• 157 Article
• 13 Review article
• 10 Doctoral thesis 1 (Research UU / Graduation UU)
• 9 Meeting Abstract
• 19 More
  • 9 Comment/Letter to the editor
  • 6 Doctoral thesis 2 (Research NOT UU / Graduation UU)
  • 4 Letter

Research output per year

Research output per year

Search results

• 2019

  Comprehensive pan-cancer analysis of somatic mutations in drug transporters to reveal acquired and intrinsic drug resistance in 3149 metastatic cancer patients

  Bins, S., van de Geer, W. S., van Riet, J., Steeghs, N., Verheul, H. M. W., van Herpen, C., Witteveen, P. O., Tjan-Heijnen, V. C. G., Lolkema, M. P., Voest, E. E., Sleijfer, S., Cuppen, E., van de Werken, H. J. G. & Mathijssen, R. H. J., Oct 2019, In: Annals of Oncology. 30

  Research output: Contribution to journal › Meeting Abstract › Academic

• Drug Rediscovery Protocol: Expanded use of existing anticancer drugs

  Voest, E. E., van der Velden, D. L., Hoes, L., Van der Wijngaart, H., Henegouwen, M. V. B., Van Werkhoven, E., Roepman, P., Huitema, A. D. R., van Herpen, C., de Groot, D. J., Devriese, L., de Jonge, M. J. A., Chalabi, M., Smit, E. F., Mehra, N., Labots, M., Sleijfer, S., Cuppen, E., Verheul, H. M. W. & Gelderblom, H., Oct 2019, In: Annals of Oncology. 30

  Research output: Contribution to journal › Meeting Abstract › Academic

• Pan-cancer whole genome analyses of metastatic solid tumors

  Cuppen, E., Priestley, P., Baber, J., Lolkema, M. P., Steeghs, N., de Bruijn, E., Duyvesteyn, K., Haidari, S., van Hoeck, A., Roepman, P., Shale, C., Voda, M., Tjan-Heijnen, V. C. G., Bloemendal, H., van Herpen, C., Labots, M., Witteveen, P. O., Smit, E. F., Sleijfer, S. & Voest, E. E., Oct 2019, In: Annals of Oncology. 30, p. 864-864

  Research output: Contribution to journal › Meeting Abstract › Academic

• Update on the Drug Rediscovery Protocol: Expanded use of existing anticancer drugs in patients with a known molecular profile.

  Henegouwen, J. M. V. B., Hoes, L. R., van der Wijngaart, H., Van der Velden, D. L., Huitema, A., Cuppen, E. P. J. G., Lugtenburg, E. J., De Vos, F. Y. F. L., Bloemendal, H., Grunberg, K., Verheul, H. M. W., Gelderblom, H. & Voest, E. E., 20 May 2019, In: Journal of Clinical Oncology. 37, 15

  Research output: Contribution to journal › Meeting Abstract › Professional

• WGS implementation in standard cancer diagnostics for every cancer patient (WIDE)

  Roepman, P., Bosch, L., Samsom, K., Schipper, L., de Bruijn, E., Hoes, L., Riethorst, I., Schoenmaker, L., van der Kolk, L., van Snellenberg, H., Voest, E. E., Cuppen, E., Monkhorst, K. & Meijer, G., Oct 2019, In: Annals of Oncology. 30, p. 575-575

  Research output: Contribution to journal › Meeting Abstract › Academic
• 2017

  An individual patient data (IPD) meta-analysis of the impact of thrombocytosis (?plts) on overall survival (OS) whilst using an intermittent chemotherapy (iCTx) strategy in advanced colorectal cancer (aCRC).

  Adams, R. A., Goey, K., Chibaudel, B., Koopman, M., Punt, C. J. A., Arnold, D., Hinke, A., Hegewisch-Becker, S., De Gramont, A., Labianca, R., Tveit, K. M., Wasan, H. S., Diaz-Rubio, E., Kaplan, R. S., Maughan, T., Brown, L. C. & Fisher, D., 20 May 2017, In: Journal of Clinical Oncology. 35, e15044.

  Research output: Contribution to journal › Meeting Abstract › Academic

  • Thrombocytosis 100%
  • Colorectal Neoplasms 60%
  • Data Analysis 57%
  • Meta-Analysis 57%
  • Drug Therapy 44%

• Expanding the use of approved drugs: The CPCT's Drug Rediscovery Protocol (DRUP)

  Voest, E., van der Velden, D., Hoes, L., Bloemendal, H., Grunberg, K., Huitema, A. D. R., Lugtenburg, E., De Vos, F., van Herpen, C., de Groot, D. J. A., Hamberg, P., Smit, E., Cuppen, E., Steeghs, N., Sleijfer, S., Verheul, H., Gelderblom, H. & van der Wijngaart, H., Nov 2017, In: Annals of Oncology. 28, 10, p. 1-1

  Research output: Contribution to journal › Meeting Abstract › Academic

• Implementation, participation and satisfaction rates of a web-based decision support tool for patients with metastatic colorectal cancer

  Keikes, L., on behalf of the, CAPS. R. P. G., Karssen, K., Mels, A., de Vos-Geelen, J. M. P. G. M., de Groot, J. W. B., Koopman, M. & van Oijen, M. G. H., Sept 2017, In: Annals of Oncology. 28, suppl_5, p. 201-202 594P.

  Research output: Contribution to journal › Meeting Abstract › Other research output

  • Oncologists 100%
  • Colorectal Neoplasms 72%
  • Patient Participation 58%
  • Patient Satisfaction 48%
  • Shared Decision Making 48%
• 2009

  TISSUE MICRO ARRAY REVEALS NOVEL PROGNOSTIC MARKERS FOR CLEAR CELL RENAL CELL CARCINOMA

  Kroeze, S. G. C., Van Melick, H. H., Vermaat, J. S., Van Diest, P. J., Voest, E. E., Bosch, J. L. H. R. & Jans, J. J. M., Mar 2009, In: European Urology Supplements. 8, 4, p. 297-297 1 p.

  Research output: Contribution to journal › Meeting Abstract › Other research output